I-Mab ADR
(IMAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMAB | LCTX | AUTL | ||
| Company | I-Mab ADR | Lineage Cell Therapeutics Inc | Autolus Therapeutics Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 4.70 | 1.7100 | 1.3900 | ||
| High | 4.77 | 1.7550 | 1.4400 | ||
| Low | 4.49 | 1.6600 | 1.3850 | ||
| Latest | 4.63 | 1.6600 | 1.4000 | ||
| Change | -0.01 | -0.0400 | +0.0200 | ||
| % Change | -0.22% | -2.35% | +1.45% | ||
| Volume | 1,517,300 | 790,100 | 926,600 | ||
| 20-Day Average Volume | 2,165,250 | 1,207,700 | 1,446,755 | ||
| Previous Close | 4.64 | 1.7000 | 1.3800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.00 | 1.6605 | 1.4145 | ||
| 20-Day Raw Stochastic | 25.00% | 46.67% | 36.73% | ||
| 20-Day Relative Strength | 50.83 | 48.96 | 45.37 | ||
| Weighted Alpha | +111.30 | +96.33 | -30.51 | ||
| Today's Opinion | 80% Buy | 8% Buy | 88% Sell | ||
| Previous Opinion | 80% Buy | 40% Buy | 88% Sell | ||
| Last Month's Opinion | 72% Buy | 48% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.94% since 10/22/25 | -2.35% since 02/06/26 | -1.41% since 02/06/26 | ||
| Low | 4.13 on 10/24/25 | 1.6500 on 02/09/26 | 1.3645 on 02/12/26 | ||
| High | 4.88 on 10/28/25 | 1.9000 on 02/10/26 | 1.4800 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +35.38% since 09/29/25 | -0.60% since 01/13/26 | +2.19% since 01/13/26 | ||
| Low | 3.46 on 09/30/25 | 1.4500 on 02/02/26 | 1.3100 on 02/05/26 | ||
| High | 6.79 on 10/16/25 | 1.9000 on 02/10/26 | 1.5550 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +172.35% since 07/29/25 | -7.78% since 11/13/25 | +9.38% since 11/13/25 | ||
| Low | 1.75 on 07/30/25 | 1.4500 on 02/02/26 | 1.2000 on 11/21/25 | ||
| High | 6.79 on 10/16/25 | 1.9550 on 11/14/25 | 2.0700 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +470.20% since 04/29/25 | +61.17% since 08/13/25 | -23.91% since 08/13/25 | ||
| Low | 0.81 on 04/30/25 | 1.0000 on 08/14/25 | 1.2000 on 11/21/25 | ||
| High | 6.79 on 10/16/25 | 2.0900 on 11/03/25 | 2.0700 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 378,086 | 382,345 | 372,600 | ||
| Shares Outstanding, K | 81,660 | 230,328 | 266,143 | ||
| Annual Sales | 0 | 9,500,000 | 10,120,000 | ||
| Annual Net Income | -22,230,000 | -18,610,000 | -220,660,000 | ||
| Last Quarter Sales | 0 | 3,680,000 | 21,190,000 | ||
| Last Quarter Net Income | -5,500,000 | -29,780,000 | -79,120,000 | ||
| 60-Month Beta | 1.45 | 1.80 | 1.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/20/25 | -0.13 on 11/06/25 | -0.30 on 11/12/25 | ||
| Latest Earnings Date | 11/13/25 | 03/09/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||